22nd June 2025

Discussion Guides: Tardive Dyskinesia Roundtable Webinar

Overview
Tardive dyskinesia (TD) is a debilitating, often irreversible movement disorder caused by prolonged exposure to dopamine receptor blocking agents (DRBAs) like antipsychotics.

22nd June 2025

Risk Factors in Tardive Dyskinesia

Expert insights on Tardive Dyskinesia risk factors

9th May 2024

Market Access Insights Deck

Explore payers’ points of view regarding the roles and coverage of currently-approved gene therapies.

9th May 2024

Market Access Insights Memo

Key Insights on Gene Therapy Coverage

9th May 2024

The Concept of Typicality and Extrapyramidal Symptoms with Antipsychotics

The newly proposed classification system for atypical antipsychotics is based on the concept of spectrum atypia.

9th May 2024

Article Summary & Polling Q&A

In this real-world study comparing viloxazine extended-release (ER) with atomoxetine for pediatric and adult
attention-deficit hyperactivity disorder (ADHD), viloxazine ER demonstrated greater improvement in total ADHD symptoms in both children and adults, and in inattention and hyperactivity/impulsivity.

9th May 2024

Survey Development_ADHD

What is your area of specialization?
a. Psychiatry
b. Family Medicine
c. Internal Medicine
d. Pediatrics
e. Other _____________

7th May 2024

Abstract

Background: Large B-cell lymphoma (BCL) patients often face poor outcomes after first or second-line
therapy failures.

13th December 2023

MTXPK.ORG

Interpreting results and planning treatment using MTXPK.ORG

13th December 2023

Why WAKIX® (pitolisant)?

13th December 2023

Advisory Board

MEETING EXECUTIVE SUMMARY: ONCOLOGY CLINICAL PATHWAY DESIGN FOR NEW DRUG INDICATIONS

11th December 2023

KOL Roundtable Discussion Guide Slide deck

Viloxazine ER Compared With Atomoxetine

1st December 2023

NP Spotlight: Chris Lambert, FNP-C, DNP | NP Psych Navigator

A career as a psychiatric nurse practitioner can be replete with challenges and opportunities. The NP Psych Navigator Spotlight is your chance to learn more about nurse practitioners who are working to advance the profession and mental health in general. In this installment of this series, we profile Chris Lambert, FNP-C, DNP.

1st December 2023

Supporting a Loved One With Major Depressive Disorder

1st December 2023

Psychopharmacology Considerations for Clinical Practice

1st December 2023

Adopting a Holistic Approach to the Management of Major Depressive Disorder (MDD)

1st December 2023

Adopting a Holistic Approach to the Management of Major Depressive Disorder (MDD) | Clinical Topics in Depression

When a patient is diagonsed with MDD, what are some benefical self-care strategies that you can suggest to help them as they begin their treatment journey, in addition to pharmacologic therapy and/or psychotherapy?

30th November 2023

Outcomes Measurement Tactics Learning Outcomes Reportable Metrics

30th November 2023

Video Transcript Part 1: Overview of case-based discussion on management of select adverse events

22nd November 2023

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

22nd November 2023

Patient Ambassador Speaker Slide Deck

22nd November 2023

Peer Reviewed Journal Supplement

16th November 2023

Storyboard

Rapid Mood Screener Tool Video

16th November 2023

(C) NP Psych Navigator 2023 ABBV-US-00976-MC, Version 1.0 Sponsored by AbbVie Medical Affairs Approved 03/2023